About this trial
This is a 16 week pilot study of the impact of a nutritionist led ketogenic diet (Ren-Nu) supplemented with the medical food KetoCitra on autosomal dominant polycystic kidney disease.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult (18 years or older)
Diagnosis of ADPKD by a physician.
Estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73 m2 at screening using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.
Appropriate control of blood pressure (i.e. entry reading <140/90) including the use of BP medications for diagnosis of hypertension.
Disqualifiers
Intolerance or allergy to any of the ingredients in the provided medical food
History of hyperkalemia
Heart failure
Liver cirrhosis
Trial design
Single group
Treatments tested in this trial
Ren-Nu and KetoCitra
Dietary supplementThis is a structured, nutritionist monitored program supplemented with a nutritional food product, while monitoring metabolic parameters
Treatment groups
Trial outcomes
Primary outcomes
Change in Serum Renal Function
Change from baseline of renal function assessment as measured by creatinine based estimated glomerular filtration rate.
Change in Serum Hepatic Function Biomarkers
Change from baseline of serum liver panel biomarkers to track safety signals. Biomarkers include: AST (U/L), ALT (U/L), and LDH (U/L). Measured via standard clinical laboratory assays.
Change in Glycemic Control
Change from baseline of glycemic control as measured by aggregate of Hgb A1c and Homeostatic model assessment of insulin resistance (HOMA-IR).
Change in Systemic Inflammation Markers
Change from baseline of inflammatory biomarkers as an aggregate using: serum C-reactive protein \[(CRP) mg/dL\] and homocysteine (umol/L). Measured via standard clinical laboratory assays.
Secondary outcomes
Change in health-related quality of life as assessed by the Quality of Life: Short-Form Health Survey 12 (SF-12v2)
Participants will complete the Quality of Life: Short-Form Health Survey 12 (SF-12v2) on Day 0 and Day 120. Scores are standardized by mean. A higher score indicates a better-than-average health-related quality of life, while a lower score suggests a below-average health-related quality of life.
Change in self reported mental and physical health outcomes
This is reported as a change in participant reported mental health status measured via both the Quality of Life: Short-Form Health Survey 12 (SF-12v2) and the study-developed Ren-Nu Outcomes survey. The outcomes survey assesses topics such as final weight (kg), final blood pressure (mmHg), current PKD related symptoms, and changes to medications/supplements.
Assessment of nutrition knowledge following the structured nutrition education program
Self reported participant nutrition knowledge of the nutritional program at the end of the program. This is a study-developed questionnaire and these questions are multiple choice with a low score reflecting lower nutritional knowledge of the dietary program and a high score reflecting higher nutritional knowledge of the dietary program.
Assessment of dietary intervention tolerability following the structured nutrition education program
Self reported participant tolerability of the nutritional program at the end of the program. This is a study-developed questionnaire and questions are multiple choice with a low score reflecting a lower tolerability to the dietary program and a high score reflecting higher satisfaction with the program.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Richard Fatica
Lead sponsor
The Cleveland Clinic
Sponsor institution
Santa Barbara Nutrients
Collaborator